565 related articles for article (PubMed ID: 15727113)
21. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
Schatzberg AF
J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
[TBL] [Abstract][Full Text] [Related]
23. Depression and anxiety: pharmacological treatment in general practice.
Ellen S; Selzer R; Norman T; Blashki G
Aust Fam Physician; 2007 Apr; 36(4):222-8. PubMed ID: 17392933
[TBL] [Abstract][Full Text] [Related]
24. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
25. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States.
Palmsten K; Hernández-Díaz S; Huybrechts KF; Williams PL; Michels KB; Achtyes ED; Mogun H; Setoguchi S
BMJ; 2013 Aug; 347():f4877. PubMed ID: 23965506
[TBL] [Abstract][Full Text] [Related]
26. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
27. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
28. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
29. Does selectivity matter?
Deakin JF
Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():13-7. PubMed ID: 8732439
[TBL] [Abstract][Full Text] [Related]
30. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
Humble M
Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
[TBL] [Abstract][Full Text] [Related]
31. Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression.
Mace S; Taylor D
Expert Opin Pharmacother; 2000 Jul; 1(5):917-33. PubMed ID: 11249500
[TBL] [Abstract][Full Text] [Related]
32. Anxiety and depression in the elderly: implications for diagnosis and treatment.
Dunner DL
CNS Spectr; 2003 Dec; 8(12 Suppl 3):5. PubMed ID: 14978457
[No Abstract] [Full Text] [Related]
33. [Individualized treatment with antidepressants].
Köhler S; Arndt A; Sterzer P; Bschor T
Fortschr Neurol Psychiatr; 2013 Feb; 81(2):104-16; quiz 117-8. PubMed ID: 23412962
[No Abstract] [Full Text] [Related]
34. New developments in the neurobiological basis of anxiety disorders.
Gorman JM; Hirschfeld RM; Ninan PT
Psychopharmacol Bull; 2002; 36 Suppl 2():49-67. PubMed ID: 12490823
[TBL] [Abstract][Full Text] [Related]
35. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
Westenberg HG
J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
[TBL] [Abstract][Full Text] [Related]
36. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.
Puech A; Montgomery SA; Prost JF; Solles A; Briley M
Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045
[TBL] [Abstract][Full Text] [Related]
37. Antidepressant effectiveness in severe depression and melancholia.
Schatzberg AF
J Clin Psychiatry; 1999; 60 Suppl 4():14-21; discussion 22. PubMed ID: 10086479
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients.
Montgomery SA
Int Clin Psychopharmacol; 1998 Sep; 13 Suppl 5():S49-54. PubMed ID: 9817621
[TBL] [Abstract][Full Text] [Related]
39. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
Stahl SM; Grady MM; Moret C; Briley M
CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
[TBL] [Abstract][Full Text] [Related]
40. Third-generation antidepressants: do they offer advantages over the SSRIs?
Olver JS; Burrows GD; Norman TR
CNS Drugs; 2001; 15(12):941-54. PubMed ID: 11735614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
